Fixing Healthcare Podcast

In this week’s episode of Medicine: The Truth, hosts Jeremy Corr and Dr. Robert Pearl probe the facts beneath healthcare biggest headlines. Today’s show features an in-depth look at sweeping federal budget cuts, the expanding (and often misunderstood) impact of GLP-1 medications and what’s destabilizing health coverage.

The conversation opens with a stark warning. Dr. Pearl reviews the president’s proposed 2027 budget, which includes a $15.8 billion reduction in healthcare spending. He explains why cuts to Medicaid, NIH research and global health programs could have consequences that extend far beyond the next fiscal year, potentially slowing innovation, increasing patient risk and shifting costs to states and families.

From there, the episode turns to one of the most asked-about topics from listeners: GLP-1 weight-loss drugs. While these medications clearly produce meaningful weight loss and improve outcomes in conditions tied to obesity, Dr. Pearl cautions that many of the broader health claims attributed to them may simply reflect the benefits of weight loss itself, not unique properties of the drugs.

Throughout the episode, an underlying truth: scientific progress continues but policy decisions, pricing dynamics and system design may limit who benefits (and at what cost).

Here are the other major storylines from episode 106:

Federal health cuts threaten long-term progress: The proposed budget reduces overall healthcare funding by 12.5%, cuts NIH support by $5 billion and consolidates public health agencies.

Global health funding drops sharply: International health spending is being cut nearly in half, while continued withdrawal from the World Health Organization leaves the U.S. more vulnerable to future pandemics.

CDC leadership signals a policy shift: The nomination of Dr. Erica Schwartz as permanent CDC director suggests a move back toward a more traditional, science-driven approach to vaccines.

RFK Jr. softens vaccine stance amid political pressure: In congressional testimony, the HHS secretary publicly acknowledged the safety and effectiveness of the measles vaccine.

GLP-1 drugs deliver clear weight loss and major benefits: Studies show 10-20% weight reduction, along with approximately 20% improvements in kidney and cardiovascular outcomes.

Many GLP-1 “breakthroughs” may reflect weight loss alone: Evidence linking these drugs to reduced cancer risk, improved cognition or lower addiction rates remains fuzzy at best.

Exercise rivals the impact of breakthrough drugs: A large study shows vigorous physical activity reduces risks of dementia, diabetes, cardiovascular disease and death at levels comparable to or greater than GLP-1 outcomes.

Stress does not directly cause cancer: Pearl explains that while many Americans believe stress leads to cancer, the real risk comes from behavioral responses such as increased smoking and alcohol use.

Concierge medicine expands access for some: Patients who can afford annual fees gain faster access and more time with physicians, but the model reduces availability for others.

China rapidly closes the drug development gap: New data show China’s share of global pharmaceutical research rising to over 32%, nearly matching the United States.

Exchange coverage declines and risk pools worsen: Millions may lose insurance due to subsidy changes, premium nonpayment and shifts to high-deductible plans.

Drug prices continue to rise despite reform efforts: Under the TrumpRx program, lower prices on select drugs have been offset by increases elsewhere, with new medications averaging $353,000 annually.

Robotics and AI may arrive faster than expected: A dramatic improvement in robot race performance leads Dr. Pearl to revise his estimate for clinical adoption of robotic procedures.

Tune in for more fact-based analysis and practical perspective on the healthcare policies, technologies and trends shaping medicine today.

* * *

Dr. Robert Pearl is the author of “ChatGPT, MD: How AI-Empowered Patients & Doctors Can Take Back Control of American Medicine” about the impact of AI on the future of medicine.

Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple, Spotify or wherever you find podcasts. Join the conversation or suggest a guest by following the show on X and LinkedIn.

The post MTT #106: Trump’s 2027 budget & the other threats to U.S. healthcare appeared first on Fixing Healthcare.

OpenAI didn’t need to convince patients to try generative AI.

According to Dr. Nate Gross, Health of Health at OpenAI, 230 million people already use ChatGPT each week to interpret lab results, prepare for visits, understand diagnoses or ask health-related questions they didn’t have time (or confidence) to raise in the exam room.

But what about clinicians?

On this episode of Fixing Healthcare, Dr. Robert Pearl and Jeremy Corr speak with Dr. Gross, who previously co-founded Doximity and Rock Health, about OpenAI’s latest step: the release of ChatGPT for Clinicians, a new offering that brings healthcare-specific AI tools directly to individual providers, without requiring access through a large health system contract.

In other words, the same capabilities previously limited to enterprise deployments are now being placed in the hands of front-line clinicians.

But as Dr. Gross makes clear in this timely interview, the story of AI in medicine is much bigger than a single product. It’s about how generative AI is beginning to reshape healthcare across three fronts at once: patients, clinicians and health systems.

Key highlights include:

Patients are already using AI at massive scale. Gross notes that roughly 40 million people turn to ChatGPT for help outside the clinical setting each day, often at night or between visits. They’re using it to understand symptoms, interpret medical advice and navigate a fragmented healthcare system.

Clinicians don’t want another AI tool. They want less friction. From documentation and inbox overload to prior authorizations and evidence review, physicians are looking for ways to reduce administrative burden and focus on patient care. Generative AI, when applied well, can help “sweep the floor” of repetitive work.

ChatGPT for clinicians expands access beyond health systems. Previously, OpenAI’s healthcare tools were deployed through enterprise environments. This new release allows individual physicians, nurses and other providers to access clinical-grade AI tools directly, regardless of where they practice.

Healthcare is shifting from “if” to “how” with AI. Health systems are no longer debating whether generative AI is real or ready. Instead, leaders are focused on how to deploy it safely, securely and in ways that improve care without introducing new risks.

Fragmentation remains healthcare’s biggest challenge. Patients often act as the “integration layer” between specialists, systems and settings. Gross sees AI as a potential tool to help synthesize information, coordinate care and improve communication across the system.

The future of care extends beyond the clinic. From chronic disease management to hospital-at-home models, AI tools could help patients better understand and follow care plans in their daily lives, improving outcomes between visits, not just during them.

Medical education and research are also evolving. Gross highlights OpenAI’s work to personalize learning for clinicians and accelerate scientific discovery, including new AI models designed to support biology, genomics and drug development.

Skepticism still matters. Despite the momentum, Gross emphasizes the importance of validation, clinician oversight and continuous feedback to ensure these tools are used responsibly and effectively.

Dr. Pearl shares his thoughts. Pearl embraces Gross’s three-part framework of patients, clinicians and health systems, but believes the greatest opportunity lies in transforming how care is delivered. From chronic disease management to AI-powered care in the home, he emphasizes that the real impact will come not from administrative gains, but from improving outcomes at scale—provided healthcare moves fast enough to keep today’s challenges from becoming tomorrow’s crises.

There’s much more in this conversation, including how healthcare leaders should think about AI in long-term planning and a deeper dive into the biggest opportunities that lie ahead.

Tune in to hear what physicians, patients and health systems should expect from the next chapter of medicine.

* * *

Dr. Robert Pearl is the bestselling author of ChatGPT, MD: How AI-Empowered Patients & Doctors Can Take Back Control of American Medicine. Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple, Spotify or wherever you find podcasts. Join the conversation or suggest a guest by following the show on X and LinkedIn.

The post FHC #212: OpenAI’s Nate Gross on ChatGPT’s next big move in healthcare appeared first on Fixing Healthcare.

In this Unfiltered episode of Fixing Healthcare, Drs. Robert Pearl and Jonathan Fisher join cohost Jeremy Corr to explore one of medicine’s least discussed forces: how professional culture gradually reshapes physician identity.

The conversation begins with relationships using an unlikely touchpoint: FX’s Love Story: John F. Kennedy Jr. & Carolyn Bessette. Using marriage, friendship, doctor-patient dynamics and colleague trust as a launching point, Pearl and Fisher examine how stress, burnout and emotional spillover affect the people clinicians care about both at home and at work. Fisher draws on his retreat work with healthcare professionals to explain why slowing down, reconnecting socially and stepping outside the clinical environment are often prerequisites for restoring empathy and perspective.

Midway through, the discussion deepens into the powerful theme introduced through the popular SHOWTIME show Billions: the way workplace environments subtly redefine who people become over time. In medicine, that process can begin as early as the first weeks of training. Small acts of conformity, repeated decisions at the edge of one’s values and cultural reinforcement gradually shift how physicians think, behave and ultimately define themselves.

The result is a larger question that runs through the entire episode: How do clinicians preserve their humanity, relationships and deepest values inside a system that often rewards speed, hierarchy and productivity over reflection and connection?

Finally, Jeremy’s closing question on behalf of patients helps to push both physicians to confront a national reality: when specialist access takes months, compassion must be communicated quickly and system design must improve the patient experience itself.

For listeners who connected with Jonathan’s discussion of physician recovery, reflection and emotional renewal, check out his upcoming ASPIRE physician retreat, a CME-accredited experience for healthcare professionals, taking place June 12-14 in Boone, North Carolina. Use code ASPIRE15 for 15% off registration.

For more unfiltered conversation, listen to the full episode and explore these related resources:

‘Just One Heart’ (Jonathan Fisher’s newest book)

‘ChatGPT, MD’ (Robert Pearl’s newest book)

Monthly Musings on American Healthcare (Robert Pearl’s newsletter)

* * *

Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple Podcasts or wherever you find podcasts. Join the conversation or suggest a guest by following the show on Twitter and LinkedIn.

The post FHC #211: How medical culture slowly reshapes physician identity appeared first on Fixing Healthcare.

In this Diving Deep episode, Dr. Robert Pearl and Jeremy Corr connect two forces that are beginning to reshape the future of medicine: healthcare’s worsening economic inefficiency and the rise of physician-built generative AI tools.

The conversation opens with a provocative interpretation of the latest U.S. jobs reports. While healthcare has become the nation’s primary engine of employment growth, Dr. Pearl argues that this is not a sign of strength. It is evidence that medicine continues to meet rising demand by adding labor instead of improving productivity. In his view, that failure to modernize is driving higher costs for employers, families and government programs while setting the stage for inevitable disruption.

From there, the discussion shifts to what that disruption could look like. Pearl outlines how generative AI could improve chronic disease monitoring, reduce unnecessary hospital stays and detect inpatient decline earlier than current workflows allow. These advances, he argues, would lower costs not by rationing care but by improving outcomes.

The second half of the episode turns to one of the most practical and exciting developments in generative AI: vibe coding. Here, Pearl explains how physicians can now use plain-English prompts to create customized digital tools that reflect their own clinical judgment and practice preferences. Rather than relying on static handouts or generic patient portals, doctors could build affordable applications that monitor patients continuously between visits and intervene earlier when problems arise.

Taken together, the episode puts forth a clear thesis: healthcare’s worsening economics are not a sign of resilience. They are a sign that medicine has failed to modernize. What’s more: generative AI, especially through vibe coding, may be the most practical path to higher-quality, lower-cost care.

For more, tune into this month’s episode and check out the links below.

Helpful links

US Jobs Report Spotlights Healthcare’s Inefficiency, Signals Disruption (Forbes)

How Vibe Coding Will Reshape Medical Practice (Forbes)

Monthly Musings on American Healthcare (RobertPearlMD.com)

* * *

Dr. Robert Pearl is the author of “ChatGPT, MD: How AI-Empowered Patients & Doctors Can Take Back Control of American Medicine.” Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple, Spotify or wherever you find podcasts. Join the conversation or suggest a guest by following the show on X and LinkedIn.

The post FHC #210: Healthcare’s productivity crisis & how vibe coding could help appeared first on Fixing Healthcare.

In this week’s episode of Medicine: The Truth, hosts Jeremy Corr and Dr. Robert Pearl balance two sides of American healthcare: the encouraging scientific advances that could help people live longer and healthier lives, and the growing affordability and trust crises threatening patients across the country.

The conversation opens on an optimistic note. Dr. Pearl highlights new Yale research showing that aging is far less deterministic than many Americans assume. Rather than a steady and unavoidable decline, the study found that nearly half of adults over 65 improved physically, cognitively or both over a 12-year period.

He pairs that story with new cardiovascular guidance from the American College of Cardiology and the American Heart Association, which shifts prevention toward a much longer time horizon and argues that earlier LDL management could prevent a significant share of heart attacks and strokes later in life.

The episode then pivots to the mounting financial and institutional pressures facing patients, hospitals and public-health agencies. From rising medical debt and medication nonadherence to declining vaccine trust, hospital cost inflation and the political barriers keeping GLP-1 drugs unaffordable in the United States, the discussion captures both the promise and the fragility of healthcare in 2026.

Here are the other major storylines from episode 105:

Supplements fail the evidence test: Pearl reviews clinical trial data showing that commonly used supplements such as fish oil, garlic, turmeric, cinnamon and red yeast rice performed no better than placebo in lowering LDL, reinforcing the continued value of lifestyle interventions and low-cost statins.

Medical costs continue to destabilize families: New Gallup-linked research shows that 82 million Americans are already making sacrifices to pay medical bills, from skipping meals to delaying retirement.

Drug unaffordability worsens medication adherence: A new KFF survey finds that nearly 60% of Americans worry about affording prescriptions, with 43% reporting they have not taken medications as prescribed because of cost.

Generative AI adoption surges among physicians: According to a new AMA survey, 81% of doctors now use generative AI in clinical practice, most commonly for documentation, literature summaries and chart support.

Hospitals face intensifying economic pressure: The American Hospital Association reports that care delivery costs rose 7.5% last year, driven by higher labor expenses, drug prices, supply inflation and sicker patients.

Trust in vaccine authorities continues to erode: Following the legal challenge to RFK Jr.’s overhaul of the federal vaccine advisory committee, new polling shows trust in federal vaccine recommendations has fallen sharply.

Newborn preventive care is now affected by distrust: Pearl warns that refusal of vitamin K shots, hepatitis B vaccination and antibiotic eye ointment at birth is rising, reversing decades of scientific progress and reintroducing preventable newborn risks.

Alzheimer’s blood tests show progress, but not prediction: New FDA-cleared blood tests can help identify Alzheimer’s disease as the likely cause of current dementia, but Dr. Pearl explains why they remain far less useful for predicting disease years before symptoms begin.

The fax machine may finally be dying: In one of the episode’s lighter moments, Dr. Pearl notes that CMS is moving to phase out fax-machine communication across HIPAA-covered entities, a long-overdue modernization step that could save taxpayers nearly $1 billion annually.

Residency match reaches record size: The 2026 residency match was the largest in history, with more than 48,000 applicants competing for over 44,000 positions.

Early heat waves carry serious health consequences: With unusual March heat across parts of the country, Dr. Pearl explains why early-season heat is especially dangerous, increasing risks of dehydration, kidney injury, cardiovascular strain and mental health emergencies.

GLP-1 drugs go generic abroad while U.S. prices stay high: As Novo Nordisk’s blockbuster GLP-1 medications go generic in India and other global markets, Dr. Pearl contrasts international pricing with U.S. costs and argues that congressional inaction on drug pricing remains one of healthcare’s clearest failures.

Tune in for more fact-based analysis and practical perspective on the healthcare stories shaping medicine today.

* * *

Dr. Robert Pearl is the author of “ChatGPT, MD: How AI-Empowered Patients & Doctors Can Take Back Control of American Medicine” about the impact of AI on the future of medicine.

Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple, Spotify or wherever you find podcasts. Join the conversation or suggest a guest by following the show on X and LinkedIn.

The post MTT #105: New science on aging, rising medical debt & healthcare’s fax problem appeared first on Fixing Healthcare.